Alterity Therapeutics Limited Stock Filter Stocks by Fundamentals
PRNAF Stock | USD 0 0.00 0.00% |
Alterity Therapeutics Limited fundamentals help investors to digest information that contributes to Alterity Therapeutics' financial success or failures. It also enables traders to predict the movement of Alterity Pink Sheet. The fundamental analysis module provides a way to measure Alterity Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alterity Therapeutics pink sheet.
Alterity |
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Alterity Fundamentals
Return On Equity | -0.39 | |||
Return On Asset | -0.26 | |||
Profit Margin | (2.51) % | |||
Operating Margin | (3.03) % | |||
Current Valuation | (7.2 M) | |||
Shares Outstanding | 2.41 B | |||
Shares Owned By Insiders | 15.14 % | |||
Shares Owned By Institutions | 0.33 % | |||
Price To Earning | 0.88 X | |||
Price To Book | 0.67 X | |||
Price To Sales | 3.12 X | |||
Gross Profit | 4.76 M | |||
EBITDA | (15.08 M) | |||
Net Income | (12.85 M) | |||
Cash And Equivalents | 34.81 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 117.49 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 7.07 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (12.34 M) | |||
Earnings Per Share | (0) X | |||
Number Of Employees | 12 | |||
Beta | 0.87 | |||
Market Capitalization | 18.77 M | |||
Total Asset | 41.36 M | |||
Retained Earnings | (125 M) | |||
Working Capital | 32 M | |||
Current Asset | 34 M | |||
Current Liabilities | 2 M | |||
Z Score | 91.2 | |||
Net Asset | 41.36 M |
About Alterity Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alterity Therapeutics Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Alterity Pink Sheet
Alterity Therapeutics financial ratios help investors to determine whether Alterity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterity with respect to the benefits of owning Alterity Therapeutics security.